[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.197.171.35. Please contact the publisher to request reinstatement.
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Citations 0
Correction
December 8, 1999

Incorrect Wording

JAMA. 1999;282(22):2124. doi:10.1001/jama.282.22.2124

In the Original Contribution entitled "Reduction of Vertebral Fracture Risk in Postmenopausal Women With Osteoporosis Treated With Raloxifene: Results From a 3-Year Randomized Clinical Trial," published in the August 18, 1999, issue of THE JOURNAL (1999;282:637-645), there was incorrect wording in 2 tables and 1 figure. On page 640 in Table 2, for study group 1, the relative risk for raloxifene 120 mg/d that read "0.5" should have read "0.6," and the total relative risk for raloxifene 120 mg/d that read "0.6" should have read "0.5." On page 641 in Table 3, the title that read "Nonvertebral Fractures in 4536 Women Receiving Raloxifene Hydrochloride Therapy and 2292 Women Receiving Placebo" should have read "Nonvertebral Fractures in 5129 Women Receiving Raloxifene Hydrochloride Therapy and 2576 Women Receiving Placebo." On page 642 in the legend for Figure 3, the sentence that read "This represents 2292 women who received placebo and 4536 women who received raloxifene therapy for osteoporosis" should have read "This represents 2576 women who received placebo and 5129 women who received raloxifene therapy for osteoporosis."

×